Day 5 embryo transfer did not increase the pregnancy rate over day 3 transfer for unselected couples in ART cycles

Evidence-based Obstetrics and Gynecology

Volumn 7, Issue 3, 2005, Pages 147-148

  Kolibianakis, E M ^b   Zikopoulos, K ^b   Verpoest, W ^b   Camus, M ^b   Joris, H ^b   Van Steirteghem, A C ^b   Devroey, P ^b   Blake, Debbie ^a  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

BELGIUM; BLASTOCYST; CLINICAL TRIAL; EMBRYO; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GESTATION PERIOD; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MALE INFERTILITY; META ANALYSIS; MULTIPLE PREGNANCY; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZATION; SHORT SURVEY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 24144439149     PISSN: 1361259X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ebobgyn.2005.06.008     Document Type: Short Survey

References (3)

1. Blake DA, Proctor M, Johnson NP. The merits of blastocyst versus cleavage stage embryo transfer: A Cochrane review. Hum Reprod 2004; 19:795-807.
2. Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Hum Reprod 2003; 18:1000-4.
3. Schwarzler P, Zech H, Auer M, et al. Pregnancy outcome after blastocyst transfer as compared to early cleavage stage transfer. Hum Reprod 2004; 19:2097-102.